DE2634433A1 - Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE2634433A1
DE2634433A1 DE19762634433 DE2634433A DE2634433A1 DE 2634433 A1 DE2634433 A1 DE 2634433A1 DE 19762634433 DE19762634433 DE 19762634433 DE 2634433 A DE2634433 A DE 2634433A DE 2634433 A1 DE2634433 A1 DE 2634433A1
Authority
DE
Germany
Prior art keywords
group
general formula
radical
methyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762634433
Other languages
German (de)
English (en)
Inventor
Graham John Durant
Charon Robin Ganellin
George Sidney Sach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of DE2634433A1 publication Critical patent/DE2634433A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19762634433 1975-07-31 1976-07-30 Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Withdrawn DE2634433A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31970/75A GB1564502A (en) 1975-07-31 1975-07-31 Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Publications (1)

Publication Number Publication Date
DE2634433A1 true DE2634433A1 (de) 1977-02-03

Family

ID=10331105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762634433 Withdrawn DE2634433A1 (de) 1975-07-31 1976-07-30 Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (31)

Country Link
US (4) US4083983A (xx)
JP (2) JPS5219671A (xx)
AR (1) AR213736A1 (xx)
AT (1) AT356132B (xx)
AU (1) AU502752B2 (xx)
BE (1) BE844504A (xx)
BG (1) BG27368A3 (xx)
CA (1) CA1068711A (xx)
CH (1) CH624938A5 (xx)
CS (1) CS189018B2 (xx)
DD (1) DD125204A5 (xx)
DE (1) DE2634433A1 (xx)
DK (1) DK316176A (xx)
ES (1) ES450310A1 (xx)
FI (1) FI762193A (xx)
FR (1) FR2319343A1 (xx)
GB (1) GB1564502A (xx)
GR (1) GR60810B (xx)
HU (1) HU173778B (xx)
IE (1) IE43508B1 (xx)
IL (1) IL50005A (xx)
LU (1) LU75507A1 (xx)
NL (1) NL7608496A (xx)
NO (1) NO762661L (xx)
PH (1) PH14555A (xx)
PL (1) PL103684B1 (xx)
PT (1) PT65348B (xx)
SE (1) SE7608477L (xx)
SU (1) SU692558A3 (xx)
ZA (1) ZA764082B (xx)
ZM (1) ZM9876A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928863A (xx) * 1972-07-13 1974-03-14
JPS5078968U (xx) * 1973-11-20 1975-07-08
ZA774220B (en) * 1976-07-28 1978-06-28 Smith Kline French Lab Pharmacologically active compounds
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
US4287346A (en) * 1979-02-16 1981-09-01 Eisai Co., Ltd. Cyanoguanidine derivatives
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPH0828166B2 (ja) * 1985-01-16 1996-03-21 松下電器産業株式会社 サ−モスタツト
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
US5380734A (en) * 1993-04-15 1995-01-10 American Home Products Corporation N-cyanoamidine derivatives as anti-influenza agents
CA3104669A1 (en) 2018-06-29 2020-01-02 410 Medical, Inc. Systems, apparatus, and methods for filtering air from a fluid line
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3908014A (en) * 1970-06-25 1975-09-23 Smith Kline French Lab Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3808336A (en) 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4002759A (en) * 1973-05-17 1977-01-11 Smith Kline & French Laboratories Limited Pyridylbutylamino ethylene compounds
US4025527A (en) * 1973-07-13 1977-05-24 Smith Kline & French Laboratories Limited Certain thiazoles and oxazoles
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives

Also Published As

Publication number Publication date
SU692558A3 (ru) 1979-10-15
US4083983A (en) 1978-04-11
GR60810B (en) 1978-08-30
CS189018B2 (en) 1979-03-30
US4264608A (en) 1981-04-28
PL103684B1 (pl) 1979-07-31
PT65348A (en) 1976-08-01
IL50005A (en) 1981-06-29
AR213736A1 (es) 1979-03-15
GB1564502A (en) 1980-04-10
US4426526A (en) 1984-01-17
ZA764082B (en) 1977-06-29
NO762661L (xx) 1977-02-01
FR2319343A1 (fr) 1977-02-25
IL50005A0 (en) 1976-09-30
IE43508B1 (en) 1981-03-11
FR2319343B1 (xx) 1978-11-17
AT356132B (de) 1980-04-10
ZM9876A1 (en) 1977-09-21
IE43508L (en) 1977-01-31
ES450310A1 (es) 1977-12-01
DK316176A (da) 1977-02-01
US4215126A (en) 1980-07-29
JPS617423B2 (xx) 1986-03-06
SE7608477L (sv) 1977-02-01
HU173778B (hu) 1979-08-28
AU502752B2 (en) 1979-08-09
CA1068711A (en) 1979-12-25
PH14555A (en) 1981-09-24
AU1645376A (en) 1978-02-02
NL7608496A (nl) 1977-02-02
CH624938A5 (xx) 1981-08-31
FI762193A (xx) 1977-02-01
DD125204A5 (xx) 1977-04-06
JPS60243069A (ja) 1985-12-03
PT65348B (en) 1978-01-06
BG27368A3 (en) 1979-10-12
LU75507A1 (xx) 1977-03-03
BE844504A (fr) 1977-01-24
JPS5219671A (en) 1977-02-15
ATA552576A (de) 1979-09-15

Similar Documents

Publication Publication Date Title
EP0001279B1 (de) Imidazolderivate deren Herstellung und diese enthaltende Präparate
DE2634433A1 (de) Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2344779A1 (de) Cyanguanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH624941A5 (xx)
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2406166A1 (de) Sulfoxide, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2634429A1 (de) Cyclobutendion- und -dithionderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2658267A1 (de) Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2847792C2 (xx)
DE2344833A1 (de) Guanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3240727A1 (de) Ergolinderivate, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE2233458A1 (de) Neue chinolinderivate
DE2710326A1 (de) Amidinoameisen- und -sulfinsaeurederivate, ihre hydrate und salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0201094A2 (de) Neue Derivate von Thieno[2,3-d]-imidazolen und Verfahren zu ihrer Herstellung
DE2634430A1 (de) Harnstoffderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0177907B1 (de) Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3438244C2 (xx)
EP0177054B1 (de) Neue Pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2634432A1 (de) Sulfoxide, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3321282A1 (de) Neue 1-acetonyl-2-(phenylimino)-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE2849572C2 (de) 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2450161C3 (de) N-ß-(3',4'-Dihydroxyphenäthyl)- glutamin und dessen Alkylester sowie deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2733952A1 (de) Alpha, omega-diaminoalkylenverbindungen
DE2650231A1 (de) Neue imidazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3129719C2 (de) Pharmazeutisches Mittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee